Tenon Medical (TNON) Director Jacques Kristine M Receives 10,147 Shares

What Happened

• Jacques Kristine M, a director of Tenon Medical (TNON), had 10,147 restricted stock units convert into 10,147 shares of common stock on July 31, 2026. The filing shows the shares were acquired at $0.00; a matching derivative disposal entry reflects the extinguishment of the RSUs.

Key Details

• Transaction date: July 31, 2026; filing date: August 4, 2026 (filed within the typical two-business-day Form 4 window).
• Reported price: $0.00 (vest/settlement; not a cash purchase or sale).
• Shares received: 10,147 common shares via conversion of RSUs.
• Shares owned after transaction: not stated in the provided filing details.
• Footnotes: F1 — conversion of 10,147 restricted stock units granted on October 13, 2025 into 10,147 shares on July 31, 2026. F2 — each RSU represents a contingent right to one share.
• Transaction codes: M (exercise/conversion of derivative). No sale or open-market transaction reported.

Context

• This was a vesting/settlement of restricted stock units (RSUs), not an open-market buy or sale. The derivative (RSU) was converted into shares and extinguished; no immediate sale of the shares is reported. Such conversions are typically routine compensation events rather than directional insider buying or selling.